Enochian Biosciences

$3.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.76%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ENOB and other stocks, options, and ETFs commission-free!

About ENOB

Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA. The listed name for ENOB is Enochian Biosciences, Inc. Common Stock.

CEO

Eric Jean Marie Leire, MD, MBA

Employees

Headquarters

Los Angeles, California

Founded

2011

Market Cap

182.49M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

164.25K

High Today

$4.06

Low Today

$3.87

Open Price

$4.01

Volume

208.01K

52 Week High

$13.43

52 Week Low

$1.95

ENOB Earnings

-$0.05

-$0.03

-$0.02

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Mar 16, Pre-Market